Chris LaVictoire Mahai, Director at abrdn Healthcare Investors (HQH), bought 501 shares at $20.96 ($11K) on 2026-07-16, disclosed to the SEC on 2026-07-20.
Director Chris LaVictoire Mahai purchased 501 shares at $20.96, marking the largest purchase of his career. This significant insider buying comes as the stock trades near its 52-week high, suggesting confidence in the healthcare asset manager's value.
HQH is currently trading at $17.92, sitting 12.41% below its 52-week high of $20.46, despite a strong 11.44% gain over the past year.
Insufficient data — needs manual review
Insufficient data — needs manual review
Something here stands out, but not much.
| Filing → |
| THW | BUY | 2026-07-20 | $11K | — | Filing → |
| MGU | BUY | 2006-09-27 | $10K | — | Filing → |